{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:26:21Z","timestamp":1771565181024,"version":"3.50.1"},"reference-count":102,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education Personnel","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Clinical practice guidelines (CPGs) are statements to assist practitioners and stakeholders in decisions about healthcare. Low methodological quality guidelines may prejudice decision-making and negatively affect clinical outcomes in non-communicable diseases, such as cardiovascular diseases worsted by poor lipid management. We appraised the quality of CPGs on dyslipidemia management and synthesized the most updated pharmacological recommendations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic review following international recommendations was performed. Searches to retrieve CPG on pharmacological treatments in adults with dyslipidaemia were conducted in PubMed, Scopus, and Trip databases. Eligible articles were assessed using AGREE II (methodological quality) and AGREE-REX (recommendation excellence) tools. Descriptive statistics were used to summarize data. The most updated guidelines (published after 2019) had their recommendations qualitatively synthesized in an exploratory analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 66 guidelines authored by professional societies (75%) and targeting clinicians as primary users were selected. The AGREE II domains Scope and Purpose (89%) and Clarity of Presentation (97%), and the AGREE-REX item Clinical Applicability (77.0%) obtained the highest values. Conversely, guidelines were methodologically poorly performed\/documented (46%) and scarcely provided data on the implementability of practical recommendations (38%). Recommendations on pharmacological treatments are overall similar, with slight differences concerning the use of supplements and the availability of drugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High-quality dyslipidaemia CPG, especially outside North America and Europe, and strictly addressing evidence synthesis, appraisal, and recommendations are needed, especially to guide primary care decisions. CPG developers should consider stakeholders\u2019 values and preferences and adapt existing statements to individual populations and healthcare systems to ensure successful implementation interventions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/fampra\/cmae029","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T06:02:54Z","timestamp":1717480974000},"page":"649-661","source":"Crossref","is-referenced-by-count":4,"title":["Methodological quality and clinical recommendations of guidelines on the management of dyslipidaemias for cardiovascular disease risk reduction: a systematic review and an appraisal through AGREE II and AGREE REX tools"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2188-9967","authenticated-orcid":false,"given":"Fl\u00e1via","family":"Deffert","sequence":"first","affiliation":[{"name":"Pharmaceutical Sciences Postgraduate Program, Universidade Federal do Paran\u00e1, Av. Pref. Loth\u00e1rio Meissner, 632, Jardim Bot\u00e2nico , Curitiba, PR 80210-170 ,","place":["Brazil"]}]},{"given":"Ana Paula Oliveira","family":"Vilela","sequence":"additional","affiliation":[{"name":"Pharmaceutical Assistance Postgraduate Program, Universidade Federal do Paran\u00e1 , Av. Pref. Loth\u00e1rio Meissner, 632, Jardim Bot\u00e2nico, Curitiba, PR 80210-170 ,","place":["Brazil"]}]},{"given":"Alexandre de F\u00e1tima","family":"Cobre","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Postgraduate Program, Universidade Federal do Paran\u00e1, Av. Pref. Loth\u00e1rio Meissner, 632, Jardim Bot\u00e2nico , Curitiba, PR 80210-170 ,","place":["Brazil"]}]},{"given":"Luiz Henrique Picolo","family":"Furlan","sequence":"additional","affiliation":[{"name":"Health Technology and Value Based Health Evaluation Sector, Unimed Paran\u00e1 , Curitiba ,","place":["Brazil"]}]},{"given":"Fernanda Stumpf","family":"Tonin","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Postgraduate Program, Universidade Federal do Paran\u00e1, Av. Pref. Loth\u00e1rio Meissner, 632, Jardim Bot\u00e2nico , Curitiba, PR 80210-170 ,","place":["Brazil"]},{"name":"Pharmaceutical Assistance Postgraduate Program, Universidade Federal do Paran\u00e1 , Av. Pref. Loth\u00e1rio Meissner, 632, Jardim Bot\u00e2nico, Curitiba, PR 80210-170 ,","place":["Brazil"]},{"name":"H&TRC - Health & Technology Research Center, ESTeSL - Escola Superior de Tecnologia da Sa\u00fade, Instituto Polit\u00e9cnico de Lisboa , Avenida D. Jo\u00e3o II, Lote 4.69.01, Parque das Na\u00e7\u00f5es, Lisboa 1990-096 ,","place":["Portugal"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-9595","authenticated-orcid":false,"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO), Institute for Health and Bioeconomy (i4HB), Laboratory of Pharmacology Department of Drug Sciences, Faculty of Pharmacy, University of Porto , Porto 4050-313 ,","place":["Portugal"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4363","authenticated-orcid":false,"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Postgraduate Program,Universidade Federal do Paran\u00e1, Av. Pref. Loth\u00e1rio Meissner, 632, Jardim Bot\u00e2nico , Curitiba, PR 80210-170 ,","place":["Brazil"]},{"name":"Pharmaceutical Assistance Postgraduate Program, Universidade Federal do Paran\u00e1 , Av. Pref. Loth\u00e1rio Meissner, 632, Jardim Bot\u00e2nico, Curitiba, PR 80210-170 ,","place":["Brazil"]}]}],"member":"286","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"2024102922015385600_CIT0001","author":"WHO. World Health Organization","year":"2021"},{"key":"2024102922015385600_CIT0002","first-page":"e30119","article-title":"A systematic review of major cardiovascular risk factors: a growing global health concern","volume":"14","author":"Adhikary","year":"2022","journal-title":"Cureus"},{"key":"2024102922015385600_CIT0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archinternmed.2009.434","article-title":"Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check","volume":"170","author":"Ferket","year":"2010","journal-title":"Arch Intern Med"},{"key":"2024102922015385600_CIT0004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2018.09.010","article-title":"Dyslipidemias in clinical practice","volume":"487","author":"Castro Cabezas","year":"2018","journal-title":"Clin Chim Acta"},{"key":"2024102922015385600_CIT0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.dsx.2020.06.010","article-title":"Management of diabetic dyslipidemia: navigating the new American and European Guidelines","volume":"14","author":"Jialal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2024102922015385600_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12170-019-0597-x","article-title":"Worldwide dyslipidemia guidelines","volume":"13","author":"Bartlomiejczyk","year":"2019","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"2024102922015385600_CIT0007","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2020.12.019","article-title":"Lipid-lowering therapy: guidelines to precision medicine","volume":"514","author":"Su","year":"2021","journal-title":"Clin Chimica Acta; Int J Clin Chem"},{"key":"2024102922015385600_CIT0008","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2024102922015385600_CIT0009","first-page":"21","article-title":"International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia","volume":"26","author":"Barter","year":"2014","journal-title":"Clin Investig Arterioscler"},{"key":"2024102922015385600_CIT0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/endrev\/bnab037","article-title":"A modern approach to dyslipidemia","volume":"43","author":"Berberich","year":"2021","journal-title":"Endocr Rev"},{"key":"2024102922015385600_CIT0011","doi-asserted-by":"crossref","first-page":"m4266","DOI":"10.1136\/bmj.m4266","article-title":"Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study","volume":"371","author":"Johannesen","year":"2020","journal-title":"BMJ"},{"key":"2024102922015385600_CIT0012","first-page":"168","article-title":".","volume-title":"Clinical Practice Guidelines: Directions for a New Program","author":"IOM. Institute of Medicine","year":"1990"},{"key":"2024102922015385600_CIT0013","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.semnuclmed.2018.11.001","article-title":"Clinical practice guidelines: tools to support high quality patient care","volume":"49","author":"Brouwers","year":"2019","journal-title":"Semin Nucl Med"},{"key":"2024102922015385600_CIT0014","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mayocp.2017.01.001","article-title":"Clinical practice guidelines: a primer on development and dissemination","volume":"92","author":"Murad","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2024102922015385600_CIT0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","article-title":"Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project","volume":"12","author":"Cluzeau","year":"2003","journal-title":"Qual Saf Health Care"},{"key":"2024102922015385600_CIT0016","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"2024102922015385600_CIT0017","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1503\/cmaj.091714","article-title":"Development of the AGREE II, part 1: performance, usefulness and areas for improvement","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ: Can Med Assoc J"},{"key":"2024102922015385600_CIT0018","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1503\/cmaj.091716","article-title":"Development of the AGREE II, part 2: assessment of validity of items and tools to support application","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ: Can Med Assoc J"},{"key":"2024102922015385600_CIT0019","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jclinepi.2020.05.025","article-title":"What to do with all the AGREEs? The AGREE portfolio of tools to support the guideline enterprise","volume":"125","author":"Brouwers","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"2024102922015385600_CIT0020","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.21037\/jtd.2019.07.71","article-title":"Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II-clinical practice guideline appraisal for lipid management in coronary heart disease","volume":"11","author":"Zhou","year":"2019","journal-title":"J Thorac Dis"},{"key":"2024102922015385600_CIT0021","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/jphs.12371","article-title":"Critical appraisal of the clinical practice guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: European society of cardiology (ESC) and European Atherosclerosis Society (ESC\/EAS) 2019 Guidelines","volume":"11","author":"Alhmoud","year":"2020","journal-title":"J. Pharm. Health Serv. Res."},{"key":"2024102922015385600_CIT0022","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019","edition":"2"},{"key":"2024102922015385600_CIT0023","volume-title":"JBI Manual for Evidence Synthesis","author":"Aromataris","year":"2020"},{"key":"2024102922015385600_CIT0024","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024102922015385600_CIT0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2018.11.030","article-title":"Systematic reviews of clinical practice guidelines: a methodological guide","volume":"108","author":"Johnston","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"2024102922015385600_CIT0026","doi-asserted-by":"crossref","first-page":"102532","DOI":"10.1016\/j.mex.2023.102532","article-title":"Systematic review of clinical practice guidelines and systematic reviews: a method for conducting comprehensive analysis","volume":"12","author":"Mancin","year":"2024","journal-title":"MethodsX"},{"key":"2024102922015385600_CIT0027","doi-asserted-by":"crossref","first-page":"e205535","DOI":"10.1001\/jamanetworkopen.2020.5535","article-title":"Development and validation of a tool to assess the quality of clinical practice guideline recommendations. article","volume":"3","author":"Brouwers","year":"2020","journal-title":"JAMA Netw Open."},{"key":"2024102922015385600_CIT0028","first-page":"1","author":"Consortium ANS","year":"2017"},{"key":"2024102922015385600_CIT0029","first-page":"1","author":"Consortium ANS","year":"2019"},{"key":"2024102922015385600_CIT0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"The Am Stat"},{"key":"2024102922015385600_CIT0031","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"290","author":"Mach","year":"2019","journal-title":"Atherosclerosis"},{"key":"2024102922015385600_CIT0032","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"2024102922015385600_CIT0033","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2024102922015385600_CIT0034","author":"NICE","year":"2023"},{"key":"2024102922015385600_CIT0035","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.jfma.2022.05.010","article-title":"2022 Taiwan lipid guidelines for primary prevention","volume":"121","author":"Huang","year":"2022","journal-title":"J Formosan Med Assoc"},{"key":"2024102922015385600_CIT0036","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/heartviews.heartviews_102_22","article-title":"2022 Saudi guidelines for the management of dyslipidemia","volume":"24","author":"AlRahimi","year":"2023","journal-title":"Heart Views"},{"key":"2024102922015385600_CIT0037","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.15420\/ecr.2021.36","article-title":"Asian Pacific Society of Cardiology consensus recommendations on dyslipidaemia","volume":"16","author":"Koh","year":"2021","journal-title":"Eur Cardiol"},{"key":"2024102922015385600_CIT0038","first-page":"787","article-title":"Atualiza\u00e7\u00e3o da diretriz de preven\u00e7\u00e3o cardiovascular da Sociedade Brasileira de Cardiologia-2019","volume":"113","author":"Pr\u00e9coma","year":"2019","journal-title":"Arq Bras Cardiol"},{"key":"2024102922015385600_CIT0039","author":"NICE","year":"2022"},{"key":"2024102922015385600_CIT0040","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Schunemann","year":"2014","journal-title":"CMAJ: Can Med Assoc J"},{"key":"2024102922015385600_CIT0041","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11948-019-00094-3","article-title":"Scientific integrity principles and best practices: recommendations from a scientific integrity consortium","volume":"25","author":"Kretser","year":"2019","journal-title":"Sci Eng Ethics"},{"key":"2024102922015385600_CIT0042","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.injury.2022.01.047","article-title":"Clinical practice guidelines: the good, the bad, and the ugly","volume":"54","author":"Guerra-Farfan","year":"2022","journal-title":"Injury"},{"key":"2024102922015385600_CIT0043","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.21037\/jtd.2017.07.30","article-title":"Guidelines for standardizing and increasing the transparency in the reporting of biomedical research","volume":"9","author":"Khan","year":"2017","journal-title":"J Thoracic Dis"},{"key":"2024102922015385600_CIT0044","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1097\/AOG.0000000000003454","article-title":"Clinical guidelines and standardization of practice to improve outcomes. ACOG Committee Opinion, Number 792","volume":"134","author":"The American College of Obstetricians and Gynecologists","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2024102922015385600_CIT0045","doi-asserted-by":"crossref","first-page":"1147458","DOI":"10.3389\/fendo.2023.1147458","article-title":"Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study","volume":"14","author":"Deravi","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024102922015385600_CIT0046","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/2050640618755002","article-title":"Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management","volume":"6","author":"de Pretis","year":"2018","journal-title":"United Eur Gastroenterol J"},{"key":"2024102922015385600_CIT0047","doi-asserted-by":"crossref","first-page":"2329133","DOI":"10.1080\/07853890.2024.2329133","article-title":"Steatotic liver disease among lean and non-lean individuals in Southern Lao PDR: a cross-sectional study of risk factors","volume":"56","author":"Homsana","year":"2024","journal-title":"Ann Med"},{"key":"2024102922015385600_CIT0048","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M17-3011","article-title":"Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk","volume":"169","author":"Yadlowsky","year":"2018","journal-title":"Ann Intern Med"},{"key":"2024102922015385600_CIT0049","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/cancers12061613","article-title":"The quality of practice guidelines for melanoma: a methodologic appraisal with the AGREE II and AGREE-REX instruments","volume":"12","author":"Steeb","year":"2020","journal-title":"Cancers (Basel)."},{"key":"2024102922015385600_CIT0050","doi-asserted-by":"crossref","first-page":"103857","DOI":"10.1016\/j.ijnurstu.2020.103857","article-title":"The quality and clinical applicability of recommendations in pressure injury guidelines: a systematic review of clinical practice guidelines. Review","volume":"115","author":"Gillespie","year":"2021","journal-title":"Int J Nurs Stud"},{"key":"2024102922015385600_CIT0051","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jad.2021.08.103","article-title":"The quality and clinical applicability of recommendations in anxiety disorders guidelines: a systematic review of seventeen guidelines from seven countries. Review","volume":"295","author":"Niu","year":"2021","journal-title":"J Affect Disord"},{"key":"2024102922015385600_CIT0052","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/jocn.16306","article-title":"Quality and clinical applicability of recommendations for incontinence-associated dermatitis: a systematic review of guidelines and consensus statements","volume":"32","author":"Chen","year":"2022","journal-title":"J Clin Nurs"},{"key":"2024102922015385600_CIT0053","doi-asserted-by":"crossref","first-page":"103193","DOI":"10.1016\/j.iccn.2021.103193","article-title":"Quality appraisal of guidelines on physical restraints in intensive care units: a systematic review","volume":"70","author":"Cui","year":"2022","journal-title":"Intensive Crit Care Nurs"},{"key":"2024102922015385600_CIT0054","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.3390\/nu14132603","article-title":"Methodological rigor and transparency in clinical practice guidelines for nutrition care in critically Ill adults: a systematic review using the AGREE II and AGREE-REX tools","volume":"14","author":"Noyahr","year":"2022","journal-title":"Nutrients"},{"key":"2024102922015385600_CIT0055","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s12094-022-02807-w","article-title":"European clinical practice guidelines on the use of chemotherapy for advanced oesophageal and gastric cancers: a critical review using the AGREE II and the AGREE-REX instruments","volume":"24","author":"Santero","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"2024102922015385600_CIT0056","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijgo.14471","article-title":"Prevention of pre-eclampsia with aspirin: a systematic review of guidelines and evaluation of the quality of recommendation evidence","volume":"161","author":"Ninan","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"2024102922015385600_CIT0057","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.aucc.2022.10.011","article-title":"A systematic review and critical appraisal of guidelines and their recommendations for sedation interruptions in adult mechanically ventilated patients","volume":"36","author":"Graham","year":"2022","journal-title":"Aust Crit Care"},{"key":"2024102922015385600_CIT0058","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00520-022-07567-5","article-title":"What information can we gain from the quality appraisal of guidelines with physical activity recommendations for cancer patients? A systematic review using the AGREE II and AGREE-REX tools","volume":"31","author":"Zhou","year":"2023","journal-title":"Support Care Cancer"},{"key":"2024102922015385600_CIT0059","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12874-023-02101-5","article-title":"Advancing guideline quality through country-wide and regional quality assessment of CPGs using AGREE: a scoping review","volume":"23","author":"Mc Allister","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"2024102922015385600_CIT0060","doi-asserted-by":"crossref","first-page":"1264717","DOI":"10.3389\/fped.2023.1264717","article-title":"A systematic review of clinical practice guidelines and recommendations for the management of pain, sedation, delirium and iatrogenic withdrawal syndrome in pediatric intensive care. Systematic Review","volume":"11","author":"MacDonald","year":"2023","journal-title":"Front Pediatr"},{"key":"2024102922015385600_CIT0061","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.3390\/nu14132603","article-title":"Methodological rigor and transparency in clinical practice guidelines for nutrition care in critically Ill adults: a systematic review using the AGREE II and AGREE-REX tools","volume":"14","author":"Noyahr","year":"2022","journal-title":"Nutrients."},{"key":"2024102922015385600_CIT0062","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s12094-022-02807-w","article-title":"European clinical practice guidelines on the use of chemotherapy for advanced oesophageal and gastric cancers: a critical review using the AGREE II and the AGREE-REX instruments","volume":"24","author":"Santero","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"2024102922015385600_CIT0063","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jclinepi.2022.06.004","article-title":"Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations","volume":"150","author":"Meneses-Echavez","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"2024102922015385600_CIT0064","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jclinepi.2023.07.013","article-title":"Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations","volume":"162","author":"Meneses-Echavez","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"2024102922015385600_CIT0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jamainternmed.2018.7529","article-title":"Factors associated with high-quality guidelines for the pharmacologic management of chronic diseases in primary care: a systematic review","volume":"179","author":"Molino","year":"2019","journal-title":"JAMA Intern Med."},{"key":"2024102922015385600_CIT0066","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1017\/S026646230300014X","article-title":"Characteristics of high-quality guidelines: evaluation of 86 clinical guidelines developed in ten European countries and Canada","volume":"19","author":"Burgers","year":"2003","journal-title":"Int J Technol Assess Health Care"},{"key":"2024102922015385600_CIT0067","doi-asserted-by":"crossref","first-page":"e25153","DOI":"10.1371\/journal.pone.0025153","article-title":"Conflict of interest in clinical practice guideline development: a systematic review","volume":"6","author":"Norris","year":"2011","journal-title":"PLoS One"},{"key":"2024102922015385600_CIT0068","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-152-11-201006010-00254","article-title":"The vexing problem of guidelines and conflict of interest: a potential solution","volume":"152","author":"Guyatt","year":"2010","journal-title":"Ann Intern Med"},{"key":"2024102922015385600_CIT0069","first-page":"302","article-title":"Racial\/ethnic-specific reference intervals for common laboratory tests: a comparison among Asians, blacks, Hispanics, and white","volume":"74","author":"Lim","year":"2015","journal-title":"Hawaii J Med Public Health"},{"key":"2024102922015385600_CIT0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4070\/kcj.2016.46.3.275","article-title":"2015 Korean guidelines for the management of dyslipidemia: executive summary (English Translation)","volume":"46","author":"Committee for the Korean Guidelines for the Management of D","year":"2016","journal-title":"Korean Circ J"},{"key":"2024102922015385600_CIT0071","doi-asserted-by":"crossref","first-page":"78","DOI":"10.12997\/jla.2019.8.2.78","article-title":"Guidelines for the management of dyslipidemia in Korea","volume":"8","author":"Rhee","year":"20182019","journal-title":"J Lipid Atheroscler"},{"key":"2024102922015385600_CIT0072","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archinte.164.12.1313","article-title":"Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study","volume":"164","author":"O\u2019Meara","year":"2004","journal-title":"Arch Intern Med"},{"key":"2024102922015385600_CIT0073","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.105.552737","article-title":"Dyslipidemia prevalence, treatment, and control in the multi-ethnic study of atherosclerosis (MESA)","volume":"113","author":"Goff","year":"2006","journal-title":"Circulation"},{"key":"2024102922015385600_CIT0074","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5551\/jat.RV16004","article-title":"Racial differences in the cholesterol-lowering effect of statin","volume":"24","author":"Naito","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"2024102922015385600_CIT0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0009-9236(01)25429-0","article-title":"Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin","volume":"70","author":"Mulder","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"2024102922015385600_CIT0076","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCGENETICS.111.961144","article-title":"Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial","volume":"5","author":"Chasman","year":"2012","journal-title":"Circ Cardiovasc Genet."},{"key":"2024102922015385600_CIT0077","volume":"95","author":"ADAPTE C","year":"2009"},{"key":"2024102922015385600_CIT0078","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1472-6947-5-23","article-title":"The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation","volume":"5","author":"Shiffman","year":"2005","journal-title":"BMC Med Inform Decis Mak"},{"key":"2024102922015385600_CIT0079","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/dc17-1795","article-title":"Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review","volume":"41","author":"Owolabi","year":"2018","journal-title":"Diabetes Care"},{"key":"2024102922015385600_CIT0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.chest.2020.09.260","article-title":"Gaps in COPD guidelines of low- and middle-income countries: a systematic scoping review","volume":"159","author":"Tabyshova","year":"2021","journal-title":"Chest"},{"key":"2024102922015385600_CIT0081","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2471\/BLT.21.285845","article-title":"Quality of stroke guidelines in low- and middle-income countries: a systematic review","volume":"99","author":"Yaria","year":"2021","journal-title":"Bull World Health Organ"},{"key":"2024102922015385600_CIT0082","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00520-022-07567-5","article-title":"What information can we gain from the quality appraisal of guidelines with physical activity recommendations for cancer patients? A systematic review using the AGREE II and AGREE-REX tools","volume":"31","author":"Zhou","year":"2023","journal-title":"Support Care Cancer"},{"key":"2024102922015385600_CIT0083","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.semnuclmed.2018.11.001","article-title":"Clinical practice guidelines: tools to support high quality patient care. review","volume":"49","author":"Brouwers","year":"2019","journal-title":"Semin Nucl Med"},{"key":"2024102922015385600_CIT0084","first-page":"857","article-title":"Simplified lipid guidelines","volume":"61","author":"Allan","year":"2015","journal-title":"Can Fam Physician"},{"key":"2024102922015385600_CIT0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11606-019-05436-2","article-title":"Engaging patients and other non-researchers in health research: defining research engagement","volume":"35","author":"Frank","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2024102922015385600_CIT0086","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hex.12467","article-title":"Framework for enhancing clinical practice guidelines through continuous patient engagement","volume":"20","author":"Armstrong","year":"2017","journal-title":"Health Expect"},{"key":"2024102922015385600_CIT0087","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11606-018-4738-6","article-title":"Practical guidance for involving stakeholders in health research","volume":"34","author":"Concannon","year":"2019","journal-title":"J Gen Intern Med"},{"key":"2024102922015385600_CIT0088","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.rdc.2022.05.002","article-title":"The meaningful role of patients, and other stakeholders in clinical practice guideline development","volume":"48","author":"Mikdashi","year":"2022","journal-title":"Rheum Dis Clin North Am"},{"key":"2024102922015385600_CIT0089","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12913-022-08165-1","article-title":"Developing integration among stakeholders in the primary care networks of Singapore: a qualitative study","volume":"22","author":"Surendran","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2024102922015385600_CIT0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jid.963","article-title":"Expanding access to priority health interventions: a framework for understanding the constraints to scaling-up","volume":"15","author":"Hanson","year":"2003","journal-title":"J Int Devel"},{"key":"2024102922015385600_CIT0091","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1186\/s12913-021-07016-9","article-title":"Stakeholder engagement in the health policy process in a low income country: a qualitative study of stakeholder perceptions of the challenges to effective inclusion in Malawi","volume":"21","author":"Masefield","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2024102922015385600_CIT0092","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/wvn.12621","article-title":"Evidence-based practice improves patient outcomes and healthcare system return on investment: findings from a scoping review","volume":"20","author":"Connor","year":"2023","journal-title":"Worldviews Evid Based Nurs"},{"key":"2024102922015385600_CIT0093","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/fampra\/cmt080","article-title":"Strategies for guideline implementation in primary care focusing on patients with cardiovascular disease: a systematic review","volume":"31","author":"Unverzagt","year":"2013","journal-title":"Fam Pract"},{"key":"2024102922015385600_CIT0094","doi-asserted-by":"crossref","first-page":"709","DOI":"10.18549\/PharmPract.2015.04.709","article-title":"Quality of drug information for healthcare professionals: The ARCA acronym","volume":"13","author":"Fernandez-Llimos","year":"2015","journal-title":"Pharm Pract (Granada)"},{"key":"2024102922015385600_CIT0095","doi-asserted-by":"crossref","first-page":"584000","DOI":"10.3389\/fpubh.2021.584000","article-title":"A review and clinical practice guideline for health professionals working with indigenous and culturally and linguistically diverse (CALD) populations during COVID-19. Policy and practice reviews","volume":"9","author":"Kayrouz","year":"2021","journal-title":"Front Public Health"},{"key":"2024102922015385600_CIT0096","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40119-022-00300-7","article-title":"Guideline LDL-C threshold achievement in acute myocardial infarction patients: a real-world evidence study demonstrating the impact of treatment intensification with PCSK9i","volume":"12","author":"Mackinnon","year":"2023","journal-title":"Cardiol Ther"},{"key":"2024102922015385600_CIT0097","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jama.2023.2487","article-title":"Treat-to-target or high-intensity statin in patients with coronary artery disease: a randomized clinical trial","volume":"329","author":"Hong","year":"2023","journal-title":"JAMA"},{"key":"2024102922015385600_CIT0098","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/CIRCULATIONAHA.121.056536","article-title":"Cardiovascular benefit of lowering low-density lipoprotein cholesterol below 40 mg\/dL","volume":"144","author":"Marston","year":"2021","journal-title":"Circulation"},{"key":"2024102922015385600_CIT0099","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12916-022-02633-5","article-title":"Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events","volume":"20","author":"Sakuma","year":"2022","journal-title":"BMC Med"},{"key":"2024102922015385600_CIT0100","first-page":"541","article-title":"Treating to target: ready, fire, aim","volume":"60","author":"Lindblad","year":"2014","journal-title":"Can Fam Physician"},{"key":"2024102922015385600_CIT0101","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2024102922015385600_CIT0102","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIR.0000000000000312","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system","volume":"133","author":"Halperin","year":"2016","journal-title":"Circulation"}],"container-title":["Family Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/fampra\/article-pdf\/41\/5\/649\/60212993\/cmae029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/fampra\/article-pdf\/41\/5\/649\/60212993\/cmae029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T22:02:25Z","timestamp":1730239345000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/fampra\/article\/41\/5\/649\/7687221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":102,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6,4]]},"published-print":{"date-parts":[[2024,10,8]]}},"URL":"https:\/\/doi.org\/10.1093\/fampra\/cmae029","relation":{},"ISSN":["1460-2229"],"issn-type":[{"value":"1460-2229","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,4]]}}}